AdWiki Webring Site
| SELECT YOUR LANGUAGE:
ar  |
id  |
bg  |
ca  |
ceb  |
cs  |
da  |
de  |
et  |
en  /  /  |
es  |
eo  |
fr  |
gr  |
he  |
hr  |
it  |
ko  |
lt  |
hu  |
nl  |
ja  |
no  |
pl  |
pt  |
ru  |
ro  |
sk  |
sl  |
sr  |
fi  |
sv  |
te  |
tr  |
uk  |
zh 
Elsilimomab
From Wikipedia, the free encyclopedia
Elsilimomab is a mouse monoclonal antibody which is used as an immunosuppressive drug.
|
Immunomodulators - Immunosuppressants - Immunosuppressive drugs (L04) |
|
| Extracellular |
|
|
CD3 ( Muromonab-CD3, Teplizumab, Visilizumab) · CD4 ( Keliximab, Zanolimumab) · CD11a ( Efalizumab) · CD20 ( Ocrelizumab, Pascolizumab) · CD23 ( Lumiliximab) · IL-2/CD25 ( Basiliximab, Daclizumab, Inolimomab) · CD40 ( Teneliximab) · CD62L/L-selectin ( Aselizumab) · CD147/Basigin ( Gavilimomab, Ziralimumab) · CD154 ( Ruplizumab)
BLyS (Belimumab) · Complement component 5 (Eculizumab) · CTLA-4 (Ipilimumab) · CAT (Metelimumab) · Immunoglobulin E (Omalizumab) · Integrin (Natalizumab) · Interleukin 5 (Mepolizumab) · Interleukin-6 receptor (Tocilizumab) · TNFs (Infliximab, Adalimumab, Certolizumab pegol, Afelimomab, Golimumab) · LFA-1 (Odulimomab)
other monoclonal: Atlizumab, Atorolimumab, Bertilimumab, Cedelizumab, Clenoliximab, Dorlimomab aritox, Dorlixizumab, Elsilimomab, Erlizumab, Faralimomab, Fontolizumab, Galiximab, Gantenerumab, Gomiliximab, Ibalizumab, Lebrilizumab, Lerdelimumab, Maslimomab, Morolimumab, Nerelimomab, Otelixizumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Toralizumab, Ustekinumab, Vapaliximab, Vepalimomab, Zolimomab aritox
Polyclonal: Anti-thymocyte globulin
|
|
|
|
|
|
|
|
|
|
|
| Intracellular |
|
|
|
Mouse monoclonal antibodies ("-o-") |
|
| "govo" (ovarian tumor) |
|
|
| "limo" (immune system) |
Afelimomab, Dorlimomab aritox, Elsilimomab, Faralimomab, Gavilimomab, Inolimomab, Maslimomab, Nerelimomab, Odulimomab, Telimomab aritox, Vepalimomab, Zolimomab aritox
|
|
| "tumo" (miscellaneous tumor) |
Altumomab, Anatumomab mafenatox, Arcitumomab, Bectumomab, Blinatumomab, Detumomab, Epitumomab, Epitumomab cituxetan, Ibritumomab tiuxetan, Minretumomab, Mitumomab, Naptumomab estafenatox, Nofetumomab merpentan, Pemtumomab, Pintumomab, Satumomab, Taplitumomab paptox, Tositumomab
|
|
| "leso" (infectious lesions) |
|
|
| "ciro" (cardiovascular) |
|
|
| "pro" (prostate tumor) |
|
|
| "baco" (bacterial) |
|
|
| "colo" (colonic tumor) |
|
|
Change language: All |
Arabic |
Indonesian |
Bulgarian |
Catalan |
Cebuano |
Czech |
Danish |
German |
Estonian |
English / / |
Spanish |
Esperanto |
French |
Greek |
Hebrew |
Croatian |
Italian |
Korean |
Lithuanian |
Hungarian |
Flemish / Dutch |
Japanese |
Norwegian |
Polish |
Portugues |
Russian |
Romanian |
Slovakian |
Slovenian |
Serbian |
Suomi / Finish |
Swedish |
Iranian |
Turkish |
Ukrainian |
Chinese
MORE LINKS...
Autorem skryptu AdWiki v0.62 (2007) jest husky83
Licencję na skrypt dla strony DAWAJ.INFO posiada dzankes
Wikipedia® jest zarejestrowanym znakiem towarowym Wikimedia Foundation |
